Chronic Functional Constipation
9
2
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
11%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (9)
Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics
The Efficacy of Long-Course Treatment Using Vibrating Capsules for Chronic Constipation
Comparative Study of Different Dosages of Vibrabot Capsule in the Treatment of Chronic Functional Constipation
Real-World Clinical Study on the Efficacy of Vibrating Capsule (Vibrabot Capsule) for Chronic Functional Constipation
Effect of Vibration Capsule on Different Subtypes of Functional Constipation
Comparative Study on the Efficacy of Vibrabot Capsule and Polyethylene Glycol for Chronic Functional Constipation
Effectiveness & Safety of Promelaxin® Microenemas Against Macrogol 4000 P.O. in Chronic Constipation in Children 6-48 Months
Fecal Microbiota Transplantation for Chronic Functional Constipation
Quality of Life in Children and Adolescents With Chronic Functional Constipation: Educational Action Effects